Advisory Committees

Briefing Information for the February 26, 2014 Meeting of the Nonprescription Drugs Advisory Committee (NDAC)

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance

FDA

Disclaimer: Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

Page Last Updated: 09/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.